Therapy News and Research

RSS

Economic blow of the coronavirus hits America’s already stressed farmers

Richard Oswald, still mourning the loss of his family's homestead to flooding along the Missouri River, is planting corn and soybeans into ground that last year was feet deep underwater.

7 May 2020

DFG to set up new clinical and research units

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is setting up three new Research Units and one new Clinical Research Unit.

7 May 2020

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

The human gut microbiota consists of trillions of bacteria, fungi and virus constituting an inner chemical factory producing a multitude of microbial compounds affecting immunity, neurobiology and metabolism of the human host.

7 May 2020

New technique could revolutionize treatment for Alzheimer's, epilepsy, brain tumors

University of Virginia researchers are pioneering the use of focused ultrasound to defy the brain's protective barrier so that doctors could, at last, deliver many treatments directly into the brain to battle neurological diseases.

7 May 2020

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Treating hospitalized COVID-19 patients with anticoagulants - blood thinners that slow down clotting - may improve their chances of survival, researchers from the Mount Sinai COVID Informatics Center report.

7 May 2020

Researchers discover previously unknown anti-phage defense mechanism in certain bacteria

Researchers from Singapore-MIT Alliance for Research and Technology, MIT’s research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.

7 May 2020

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

The COVID-19 pandemic caused by the severe acute respiratory syndrome -coronavirus 2 (SARS-CoV-2) has spread to most of the world, causing millions of cases and hundreds of thousands of deaths. A new study published on the preprint server bioRxiv* shows that a protease inhibitor drug already approved by the Food and Drug Administration (FDA) could inhibit viral entry.

6 May 2020

New anti-phage defense mechanism in bacteria protects their DNA, finds study

Researchers from Singapore-MIT Alliance for Research and Technology, MIT's research enterprise in Singapore, have discovered a new anti-phage defense mechanism found in some bacteria, which uses previously unknown features to protect their DNA.

6 May 2020

Combination therapy trial to understand the biology, spread, treatment of COVID-19

The HonorHealth Research Institute and HonorHealth announced today the successful enrollment on a novel combination of atovaquone and azithromycin in patients with moderate-to-severe COVID-19 infection.

6 May 2020

New trial platform could help evaluate potential therapies for Parkinson’s disease

Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease.

6 May 2020

Study identifies protein vital for liver restoration and regeneration after transplant

Researchers from the Faculty of Medicine of the University of Barcelona and the CELLEX Biomedical Research Centre from IDIBAPS have identified in a study with mice a protein which is fundamental to guarantee the restoration and regeneration of the liver after a transplant or hepatic surgery.

6 May 2020

Interleukin-12 electroporation led to clinical responses in patients with advanced melanoma

Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.

6 May 2020

OXGENE™ reports third consecutive year of 100% year on year revenue growth

OXGENE™ has more than doubled its annual revenue in the financial year just closed, in the third consecutive year of 100% year on year revenue growth.

From OXGENE 6 May 2020

New preclinical study shows promise for treating necrotizing enterocolitis

Necrotizing enterocolitis (NEC), a rare inflammatory bowel disease, primarily affects premature infants and is a leading cause of death in the smallest and sickest of these patients.

6 May 2020

New tool may offer a novel approach to prevent multiple chronic diseases

A study just released by Columbia University Mailman School of Public Health is reporting a blood-DNA-methylation measure that is sensitive to variation in the pace of biological aging among individuals born the same year.

6 May 2020

Cytokine storms created by COVID-19 could be reduced by using blood filter

Cytokine storms created by COVID-19 are causing major organ destruction and death, and for the first time in the United States, when patients begin to show signs of trouble, physicians are replacing the usual filter in a kidney dialysis machine with a filter known to trap these tiny proteins, with the goal of avoiding the devastation.

6 May 2020

Cat coronavirus drug shows promise for treatment of COVID-19

“They are strong drug candidates for the treatment of human coronavirus infections because they have already been successful in animals (cats),” writes the team. “The work here lays the framework for their use in human trials for the treatment of COVID-19.”

5 May 2020

Therapy News and Research

Economic blow of the coronavirus hits America’s already stressed farmers

DFG to set up new clinical and research units

Cholesterol lowering drugs can improve composition of gut bacteria in obese individuals

New technique could revolutionize treatment for Alzheimer's, epilepsy, brain tumors

Treating hospitalized COVID-19 patients with anticoagulants may improve their survival chances

Researchers discover previously unknown anti-phage defense mechanism in certain bacteria

Study discovers inhibition of SARS-CoV-2 entry priming protein by approved drug

New anti-phage defense mechanism in bacteria protects their DNA, finds study

Combination therapy trial to understand the biology, spread, treatment of COVID-19

New trial platform could help evaluate potential therapies for Parkinson’s disease

Study identifies protein vital for liver restoration and regeneration after transplant

Interleukin-12 electroporation led to clinical responses in patients with advanced melanoma

OXGENE™ reports third consecutive year of 100% year on year revenue growth

New preclinical study shows promise for treating necrotizing enterocolitis

New tool may offer a novel approach to prevent multiple chronic diseases

Cytokine storms created by COVID-19 could be reduced by using blood filter

Cat coronavirus drug shows promise for treatment of COVID-19

Growth hormone plays a key role in increasing survival rates following liver surgery

Study: Individuals at high risk of knee arthritis can indulge in vigorous exercise

New study may facilitate personalized therapy for depression, other neurological disorders

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News